Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations

L.A. McKeown

January 31, 2025

News Daily News

Dramatic LDL Drops Seen in PAD Patients With Team-Based Care

L.A. McKeown

June 18, 2024

News Daily News

AHA Celebrates a Century by Looking Back, and Forward

Shelley Wood

June 10, 2024

News Daily News

Increased Lp(a) Ups CV Risk Regardless of hs-CRP Level

Yael L. Maxwell

February 15, 2024

News Daily News

Even Low Levels of ApoB and LDL Linked With CAD, Mortality: UK Biobank

Michael O'Riordan

January 23, 2024

News Features

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

Todd Neale

December 10, 2019

News Opinion Editor's Corner

ISCHEMIA Questions? Some Answers From David Maron

Shelley Wood

December 09, 2019

News Daily News

PolyIran: Polypill Prevents Major Cardiovascular Events Over 5 Years

Todd Neale

August 23, 2019

News Daily News

Most Supplements and Diets Don’t Lower CVD or Mortality Risks

Michael O'Riordan

July 09, 2019

News Conference News SCAI 2019

LDL Apheresis Potentially a ‘Head Start’ to Conventional Lipid-Lowering Methods Post-PCI in ACS: PREMIER

Yael L. Maxwell

June 03, 2019

News Daily News

Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD

L.A. McKeown

April 03, 2019

News Daily News

Rising Number of CV-Related Maternal Deaths Spurs Need for #CardioObstetrics

Caitlin E. Cox

February 27, 2019

News Daily News

Most Cardiovascular Drugs Can Be Safely Used in Pregnancy, Review Suggests

Todd Neale

February 01, 2019

News Conference News AHA 2018

Sit Less, Move More: New Physical Activity Guidelines Stress Movement at All Ages

Michael O'Riordan

November 12, 2018

News Daily News

In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check

Caitlin E. Cox

August 15, 2018

News Daily News

Global Burden of HIV-Related CVD Has Tripled Over Two Decades

Lucy Hicks

July 13, 2018

News Industry News

New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets

June 19, 2015

Advertisement

Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations

Dramatic LDL Drops Seen in PAD Patients With Team-Based Care

AHA Celebrates a Century by Looking Back, and Forward

Increased Lp(a) Ups CV Risk Regardless of hs-CRP Level

Even Low Levels of ApoB and LDL Linked With CAD, Mortality: UK Biobank

Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019

ISCHEMIA Questions? Some Answers From David Maron

PolyIran: Polypill Prevents Major Cardiovascular Events Over 5 Years

Most Supplements and Diets Don’t Lower CVD or Mortality Risks

LDL Apheresis Potentially a ‘Head Start’ to Conventional Lipid-Lowering Methods Post-PCI in ACS: PREMIER

Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD

Rising Number of CV-Related Maternal Deaths Spurs Need for #CardioObstetrics

Most Cardiovascular Drugs Can Be Safely Used in Pregnancy, Review Suggests

Sit Less, Move More: New Physical Activity Guidelines Stress Movement at All Ages

In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check

Global Burden of HIV-Related CVD Has Tripled Over Two Decades

New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content